Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Dana-Farber, University of Texas, VU University Amsterdam


Title: Methods of Treating Meiotic Kinesin-associated Disease

Patent Number: 8,629,118

Filed: April 7, 2011

Inventor: David Pellman, Dana-Farber Cancer Institute

Title: Dual Targeting of miR-208 and miR-499 in the Treatment of Cardiac Disorders

Patent Number: 8,629,119

Filed: Feb. 4, 2010

Lead Inventor: Eric Olson, University of Texas (Miragen Therapeutics)

Title: Plant Nucleic Acids Associated with Cellular pH and Uses Thereof

Patent Number: 8,629,258

Filed: June 4, 2009

Lead Inventor: Francesca Quattrocchio, VU University Amsterdam

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.